Clinical Trial Update: Phase II Study of Revlimid®, Oral Cyclophosphamide and Prednisone for Patients With Newly Diagnosed Multiple Myeloma [Phase 2]

View source ↗

Summary

This Phase II trial evaluated a regimen of Revlimid (lenalidomide) with oral cyclophosphamide and prednisone in newly diagnosed multiple myeloma; results were p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Cytoxan (cyclophosphamide)
• Deltasone (prednisone)
• Revlimid (lenalidomide)

Snippet

Sponsor: Attaya Suvannasankha | Conditions: Multiple Myeloma | Phase 2 | Status: COMPLETED | Results posted: 2016-06-21